Jessica E Wijngaarden

ORCID

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 8

Top Venues

EJNMMI research

EJNMMI physics

Cancers

European journal of nuclear medicine and molecular imaging

This page only lists publications with an associated author ORCID identifier.

Publications

Jessica E Wijngaarden, Amina Ahbari, Johanna E E Pouw, Henri N J M Greuter, Idris Bahce, Gerben J C Zwezerijnen, Daniëlle J Vugts, Guus A M S van Dongen, Ronald Boellaard, C Willemien Menke-van der Houven van Oordt, Marc C Huisman
How to obtain the image-derived blood concentration from 89 Zr-immuno-PET scans. EJNMMI physics 11 (1) (2024)
Jessica E Wijngaarden, Amina Ahbari, Johanna E E Pouw, Henri N J M Greuter, Idris Bahce, Gerben J C Zwezerijnen, Daniëlle J Vugts, Guus A M S van Dongen, Ronald Boellaard, C Willemien Menke-van der Houven van Oordt, Marc C Huisman
How to obtain the image-derived blood concentration from 89 Zr-immuno-PET scans. EJNMMI physics 11 (1) (2024)
Jessica E Wijngaarden, Yvonne W S Jauw, Gerben J C Zwezerijnen, Berlinda J de Wit-van der Veen, Daniëlle J Vugts, Josée M Zijlstra, Guus A M S van Dongen, Ronald Boellaard, C Willemien Menke-van der Houven van Oordt, Marc C Huisman
Non-specific irreversible 89 Zr-mAb uptake in tumours: evidence from biopsy-proven target-negative tumours using 89 Zr-immuno-PET. EJNMMI research 14 (1) (2024)
Jessica E Wijngaarden, Yvonne W S Jauw, Gerben J C Zwezerijnen, Berlinda J de Wit-van der Veen, Daniëlle J Vugts, Josée M Zijlstra, Guus A M S van Dongen, Ronald Boellaard, C Willemien Menke-van der Houven van Oordt, Marc C Huisman
Non-specific irreversible 89 Zr-mAb uptake in tumours: evidence from biopsy-proven target-negative tumours using 89 Zr-immuno-PET. EJNMMI research 14 (1) (2024)
Jessica E Wijngaarden, Yvonne W S Jauw, Gerben J C Zwezerijnen, Berlinda J de Wit-van der Veen, Daniëlle J Vugts, Josée M Zijlstra, Guus A M S van Dongen, Ronald Boellaard, C Willemien Menke-van der Houven van Oordt, Marc C Huisman
Non-specific irreversible 89 Zr-mAb uptake in tumours: evidence from biopsy-proven target-negative tumours using 89 Zr-immuno-PET. EJNMMI research 14 (1) (2024)
Iris H C Miedema, Jessica E Wijngaarden, Johanna E E Pouw, Gerben J C Zwezerijnen, Hylke J Sebus, Egbert Smit, Adrianus J de Langen, Idris Bahce, Andrea Thiele, Daniëlle J Vugts, Ronald Boellaard, Marc C Huisman, C Willemien Menke-van der Houven van Oordt
89 Zr-Immuno-PET with Immune Checkpoint Inhibitors: Measuring Target Engagement in Healthy Organs. Cancers 15 (23) (2023)
Jessica E Wijngaarden, Marc C Huisman, Yvonne W S Jauw, Guus A M S van Dongen, Henri N J M Greuter, Robert C Schuit, Matthew Cleveland, Elske C Gootjes, Daniëlle J Vugts, C Willemien Menke-van der Houven van Oordt, Ronald Boellaard
Validation of simplified uptake measures against dynamic Patlak K i for quantification of lesional 89 Zr-Immuno-PET antibody uptake. European journal of nuclear medicine and molecular imaging (2023)
Jessica E Wijngaarden, Marc C Huisman, Johanna E E Pouw, C Willemien Menke-van der Houven van Oordt, Yvonne W S Jauw, Ronald Boellaard
Optimal imaging time points considering accuracy and precision of Patlak linearization for 89 Zr-immuno-PET: a simulation study. EJNMMI research 12 (1) (2022)

Jessica E Wijngaarden.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Jessica E Wijngaarden